Market Overview:
The global BRD treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of BRD, rising demand for meat products, and technological advancements in the field of veterinary medicine. The antibiotics segment is expected to dominate the market during the forecast period owing to their high efficacy in treating BRD. However, vaccines are projected to grow at a higher CAGR during the forecast period as they are becoming increasingly popular among livestock owners owing to their benefits such as prevention of diseases and reduction in overall costs associated with livestock production. North America is estimated to account for majority share of the global BRD treatment market followed by Europe and Asia Pacific during 2018-2030.
Product Definition:
BRD Treatment is a veterinary term that stands for Bovine Respiratory Disease Treatment. BRD is a highly contagious respiratory infection in cattle that can cause severe breathing problems and even death. The treatment of BRD involves antibiotics to kill the bacteria causing the infection, as well as supportive care to help the animal recover. The importance of BRD treatment lies in its ability to prevent the spread of disease and protect cattle herds from significant losses.
Antibiotics:
Antibiotics Market is expected to grow at a lucrative rate during the forecast period owing to rise in prevalence of bacterial infections. According to CDC, around 2 million people die every year due to antibiotic-resistant bacteria. This has led pharmaceutical companies and government agencies such as FDA, EMA & WHO encouraging use of new generation antibiotics with less harmful side effects which will help curb the incidence rate over coming decade or so.
Vaccines:
Vaccines are biological agents used to stimulate the body's immune system to act against an infection. There are two types of vaccines, attenuated and inactivated. Attenuated vaccines contain active ingredients that help fight diseases like measles, mumps, and rubella (MMR). Inactivated vaccine works by introducing a dead or weakened virus into the body; it is commonly used for colds and flu prevention.
Application Insights:
The others application segment accounted for the largest revenue share in 2017 and is anticipated to witness significant growth over the forecast period. This can be attributed to increasing R&D activities pertaining to new drug development, biologics production and other therapeutic applications. Increasing government funding for clinical research is also expected to contribute significantly towards market growth over the coming years.
Clinical medicine was estimated as the largest revenue-generating segment owing to increasing product usage in various disease states such as HIV infection/AIDS, cancer & tumor progression, autoimmune diseases & inflammatory bowel disease etc., across several regions of the world. The availability of a wide range of products that are used either alone or in combination with antibiotics further boosts their demand within this segment.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position during the forecast period. This can be attributed to rising investments by international companies, such as Merck & Co., Ltd., Sanofi Pasteur MSD, Novartis AG, and GlaxoSmithKline plc. These companies are focusing on expanding their operations in this region due to favorable government policies regarding research grants and low-cost labor.
Growth Factors:
- Increasing incidence of respiratory diseases: The global incidence of respiratory diseases is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for BRD treatment products and services in the coming years.
- Growing awareness about BRD: There is a growing awareness among people about bronchitis, its causes, symptoms, and treatment options. This is likely to boost the demand for BRD treatments in the near future.
- Rising number of smokers: The number of smokers across the globe is rising at an alarming rate, which in turn is leading to an increase in cases of bronchitis and other respiratory disorders. This will create a high demand for BRD treatments over the next few years.
- Technological advancements: The development of new technologies has led to better diagnosis and treatment options for bronchitis and other respiratory disorders Consequently, this will spur growth in th eBRD Treatment market overthe forecast period . 5)Growing population base:The global population baseisgrowing rapidlyand thiswill leadtoanincreaseinthedemandforBRDTreatmentproductsandservicesin thenearfuture
Scope Of The Report
Report Attributes
Report Details
Report Title
BRD Treatment Market Research Report
By Type
Antibiotics, Vaccines
By Application
Clinical Medicine, Scientific Research, Others
By Companies
Bayer HealthCare, Boehringer Ingelheim, Elanco, Merck, Zoetis, Bimeda, Ceva, Huvepharma, Inovio Pharmaceuticals, Med-Pharmex, Bayer HealthCare, Plumbline Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global BRD Treatment Market Report Segments:
The global BRD Treatment market is segmented on the basis of:
Types
Antibiotics, Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Medicine, Scientific Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer HealthCare
- Boehringer Ingelheim
- Elanco
- Merck
- Zoetis
- Bimeda
- Ceva
- Huvepharma
- Inovio Pharmaceuticals
- Med-Pharmex
- Bayer HealthCare
- Plumbline Life Sciences
Highlights of The BRD Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Vaccines
- By Application:
- Clinical Medicine
- Scientific Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the BRD Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
BRD treatment is a type of cancer therapy that uses radiation and chemotherapy to kill cancer cells.
Some of the major companies in the brd treatment market are Bayer HealthCare, Boehringer Ingelheim, Elanco, Merck, Zoetis, Bimeda, Ceva, Huvepharma, Inovio Pharmaceuticals, Med-Pharmex, Bayer HealthCare, Plumbline Life Sciences.
The brd treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 BRD Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 BRD Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 BRD Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the BRD Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global BRD Treatment Market Size & Forecast, 2020-2028
4.5.1 BRD Treatment Market Size and Y-o-Y Growth
4.5.2 BRD Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinical Medicine
6.2.2 Scientific Research
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global BRD Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 BRD Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinical Medicine
9.10.2 Scientific Research
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinical Medicine
10.10.2 Scientific Research
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinical Medicine
11.10.2 Scientific Research
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinical Medicine
12.10.2 Scientific Research
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinical Medicine
13.10.2 Scientific Research
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 BRD Treatment Market: Competitive Dashboard
14.2 Global BRD Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer HealthCare
14.3.2 Boehringer Ingelheim
14.3.3 Elanco
14.3.4 Merck
14.3.5 Zoetis
14.3.6 Bimeda
14.3.7 Ceva
14.3.8 Huvepharma
14.3.9 Inovio Pharmaceuticals
14.3.10 Med-Pharmex
14.3.11 Bayer HealthCare
14.3.12 Plumbline Life Sciences
